Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: Veterinary medicine
Package code: 1664096
Name of medicinal product: Butagran Equi
Active substances:
Phenylbutazone
Estonian, English, Latin
ATC code: QM01AA01
Dosage form: oral powder
Route of administration: oral use
Strengh: 200mg 1g
Amount in package: 5g 20TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: The product is indicated for the treatment of musculo-skeletal conditions where relief from pain and a reduction in the associated inflammation is required e.g. in lameness associated with osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation, particularly where continued mobility is considered desirable. It is also of value in limiting post-surgical inflammation, myositis and other soft tissue inflammation. The product can be used as an anti-pyretic where this is considered advisable e.g. in viral respiratory infections.
Safety features: No
Summary of product characteristics (SPC):  (last updated January 31, 2018)
Package information leaflet (PIL): EST  (last updated January 31, 2018)
Labelling:  (last updated January 31, 2018)
Withdrawal time: Mitte kasutada hobustel, kelle liha kavatsetakse tarvitada inimtoiduks. Ravitud hobuseid ei tohi kunagi inimtoiduks kasutada. Kohaliku seadusandluse järgi peab hobuse passi tegema märkuse, et hobune ei ole ette nähtud inimtoiduks tapmiseks.
Species: hobune
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Dopharma Research B.V. 
Marketing authorization number: 1751 
Marketing authorization issued on: February 1, 2013 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Decentralised 
Entry/Changing date: October 23, 2018
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere